See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Essential Omegas, Flaxseed Omega 3-6-9, Holista Omega 3, Nordic Naturals, Omega 3, Omega 3 Complex, Omega 3 w/Evening Primrose Oil, Omega 3-6-9, Omega 3-6-9 w/Astaxanthin, PharmaOmega Life, Super Omega 3, Vital Health Salmon Oil
Generic Name: Omega Fatty Acids
See also:
Lovaza
What is Omega Fatty Acids? There are two families of essential fatty acids, or EFAs: omega-3 (n−3) and omega-6 (n−6). Food sources are fish and shellfish, flaxseed, hemp oil, soya oil, canola oil, chia seeds, pumpkin seeds, sunflower seeds, leafy vegetables, and walnuts.
See more information, including instructions, precautions, side effects, and interactions.
676 patients in the community are taking or have taken Omega Fatty Acids.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| General health | 395 | 64% |
| Slow my MS progress | 111 | 17% |
| Other | 59 | 9% |
| Don't know | 9 | 1% |
| Brain fog | 8 | 1% |
| Depression | 7 | 1% |
| Stiffness/spasticity | 6 | <1% |
| Fatigue | 5 | <1% |
| Pain | 3 | <1% |
| Anxiety | 3 | <1% |
| Cognitive confusion | 2 | <1% |
| Dry eyes/burning eyes | 1 | <1% |
| Memory lapses ("brain blinks") | 1 | <1% |
| Excessive daytime sleepiness (somnolence) | 1 | <1% |
| Mood swings | 1 | <1% |
| Bowel problems | 1 | <1% |
| Bladder problems | 1 | <1% |
| disease-related symptoms | 1 | <1% |
| Emotional lability | 1 | <1% |
| Support another treatment | 1 | <1% |
Based on the patients currently taking Omega Fatty Acids.
Top 10 (Show all)
All (Show Top 10)
| 0 - day | 0 mg day | 0 day | 1 intl units day | 1 mg day | 1 other day | 1 tbs. day | 1 tps. day | 1 day | 2 g day | 2 mg day | 2 other day | 2 tbs. day | 2 day | 2.5 mg day | 3 mg day | 3 tbs. day | 4 mg day | 5 mg day | 6 mg day | 10 mg day | 14 mg day | 25 mg day | 30 mg day | 40 mg day | 50 mg day | 60 mg day | 100 mg day | 180 mg day | 200 mg day | 240 mg day | 250 mg day | 300 mg day | 336 mg day | 350 mg day | 400 mg day | 400 day | 450 mg day | 500 mg day | 600 mg day | 766 mg day | 800 mg day | 900 mg day | 1000 intl units day | 1000 mg day | 1000 day | 1100 mg day | 1200 mg day | 1250 mg day | 1260 mg day | 1300 mg day | 1500 mg day | 1520 mg day | 1600 mg day | 1800 mg day | 2000 mg day | 2200 mg day | 2400 mg day | 2450 mg day | 2600 mg day | 2700 mg day | 3000 mg day | 3200 mg day | 3600 mg day | 4000 mg day | 4000 day | 4800 mg day | 5000 mg day | 6000 mg day | 6600 mg day | 8000 mg day | 9000 mg day | 10000 mg day | 15000 mg day | 18000 mg day | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
8
|
206
|
1
|
1
|
7
|
2
|
2
|
1
|
3
|
1
|
3
|
1
|
1
|
1
|
2
|
2
|
1
|
1
|
2
|
1
|
3
|
1
|
2
|
2
|
1
|
1
|
1
|
5
|
1
|
10
|
1
|
2
|
7
|
1
|
1
|
4
|
1
|
1
|
14
|
6
|
1
|
2
|
5
|
1
|
106
|
1
|
3
|
39
|
1
|
1
|
4
|
3
|
1
|
2
|
1
|
40
|
1
|
18
|
1
|
1
|
1
|
27
|
1
|
4
|
8
|
1
|
1
|
2
|
6
|
1
|
1
|
2
|
1
|
1
|
1
|
||
How long current patients have been taking Omega Fatty Acids or how long patients were taking Omega Fatty Acids before stopping.
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Other | 14 | 54% | |
| Did not seem to work | 3 | 12% | |
| Side effects too severe | 3 | 12% | |
| Expense | 2 | 8% | |
| Personal research | 2 | 8% | |
| Course of treatment ended | 2 | 8% | |
| Doctor's advice | 1 | 4% | |
| Not indicated | 1 | 4% |
Results from 6 patient evaluations. See the overall results and all individual evaluations.
| Major | 33% | 1 |
|---|---|---|
| Moderate | 33% | 1 |
| Can't tell | 33% | 1 |
General health
| Severe | 0% | 0 |
|---|---|---|
| Moderate | 0% | 0 |
| Mild | 17% | 1 |
| None | 83% | 5 |
Top reported side-effects include: Indigestion
Summary results are based on 6 individual responses. For more information, see overall results for Adherence, Burden and Cost.